I-Mab
ANTI-IFNAR1 ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES

Last updated:

Abstract:

Provided are antibodies or fragments thereof having binding specificity to the human interferon alpha and beta receptor subunit 1 (IFNAR1) protein. In various examples, the antibodies or fragments thereof include a VH and VL CDRs as provided, or variants thereof. Methods of using the antibodies or fragments thereof for treating autoimmune diseases and disorders are also provided.

Status:
Application
Type:

Utility

Filling date:

18 Sep 2019

Issue date:

24 Dec 2020